aluminum hydroxide / magnesium trisilicate Pill

RxNorm concept 1155947, clinical dose form group (scdg).

RxCUI: 1155947
Term type: Clinical dose form group (SCDG)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1155947 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Related concepts

aluminum hydroxide (IN, has ingredient)
magnesium trisilicate (IN, has ingredient)
Gaviscon Chewable Pill (SBDG, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 1155947 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1155947 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1155947. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.